Nephros, Inc.
NEPH
$4.30
$0.112.63%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -57.53% | 59.89% | 90.71% | 163.32% | -71.01% |
Total Depreciation and Amortization | -17.50% | 14.29% | 6.06% | -5.71% | 2.94% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -92.86% | -66.91% | 450.00% | 566.67% | -91.94% |
Change in Net Operating Assets | 255.24% | -223.78% | 139.40% | -258.40% | 63.76% |
Cash from Operations | 208.70% | -75.31% | 309.31% | -24.35% | 25.45% |
Capital Expenditure | -- | -- | -- | 100.00% | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | 100.00% | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 0.00% | 0.00% | -- | 100.00% | 0.00% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 0.00% | 0.00% | -- | 100.00% | 0.00% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 209.35% | -75.36% | 309.15% | -12.66% | 17.95% |